AirSculpt Technologies, Inc. AIRS

FY2025 · ended Dec 31, 2025 · Revenue $151.82M, -15.8% YoY · Filed Apr 6, 2026

AirSculpt Technologies, Inc. (AIRS) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $151.8 million and a net loss of $11.7 million. Free cash flow was $692,000. As of Jun 30, 2026 it held $18.8 million in cash and investments and $70.5 million in total debt.

Revenue (TTM)
$150.72M
-8.7% vs year-ago TTM
Net income (TTM)
$-11.74M
+17.8% vs year-ago TTM
Operating cash flow (TTM)
$1.28M
-87.7% vs year-ago TTM
Free cash flow (TTM)
$760,000
+483.8% vs year-ago TTM
EPS (TTM)
$-0.18
+27.4% vs year-ago TTM
Dividend per share
$0.41
Shares outstanding
70.55M
+20.4% vs prior year
Net cash
$-51.64M
as of Jun 30, 2026
Operating margin
-8.4%
FY 2026

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
AIRS (Nasdaq)
Fiscal year ends
December 31
Headquarters
Tampa, FL
SEC filer status
, Emerging growth company
SEC CIK
1870940

Other Services-Offices & Clinics of Doctors of Medicine companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$151.8M
$180.3M
$195.9M
$168.8M
$133.3M
Operating income
-$11.6M
-$1.6M
$9.7M
-$4.5M
$15.8M
Net income
-$11.7M
-$8.0M
-$4.2M
-$14.7M
$10.6M
Diluted EPS
-$0.19
-$0.14
-$0.08
-$0.26
-$0.01
Operating cash flow
$3.1M
$11.3M
$24.0M
$24.4M
$26.6M
Free cash flow
$692,000
-$2.7M
$14.0M
$11.5M
$19.5M
Total assets
$187.3M
$212.8M
$204.0M
$200.8M
$200.6M
Total liabilities
$99.6M
$134.6M
$120.0M
$130.0M
$117.0M
Stockholders' equity
$87.7M
$78.2M
$82.7M
$70.8M
$83.5M
Cash and investments
$8.4M
$8.2M
$10.3M
$9.6M
$25.3M
Total debt
$83.6M
$100.1M
$99.7M
$107.6M
$100.6M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Other events
Aug 12, 2026 Aug 5, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Shareholder vote results
May 14, 2026 May 12, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 8, 2026 May 8, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.